Orally administered vaccine can protect millions from hepatitis B. Oral vaccines are both safer and less expensive than injections. Therefore, researchers are continuously pursuing ways to produce an oral vaccine that is sufficiently effective. Now, University of Copenhagen physicists have delivered virologists a “recipe” for improving vaccine drops using methods from the world of nanophysics.
Millions of people are infected with hepatitis B every year. Hundreds of thousands die. And small children are particularly at risk. Due to high cost and the stable environmental conditions required for vaccine storage, many people in developing countries are not vaccinated against this dangerous virus. As such, researchers have been working to produce a drop or powdered form of oral vaccine. Oral vaccinations are cheaper and more easily administered than injections. However, developing a sufficiently effective oral hepatitis B vaccine has so far eluded researchers.
A joint collaboration from physicists at the Niels Bohr Institute, a team of researchers from University of São Paulo together with the Butantan Institute has introduced a technique to the pharmaceutical world that just might do the trick and lead to an optimal oral Hepatitis B vaccine.
“We have used a technology commonly used in solid state physics to explore how the vaccine behaves within a particular type of encapsulation. This has yielded crucial information that would not otherwise have been achievable. When we scientists venture beyond our comfort zone and deploy each other’s knowledge across disciplines, entirely new possibilities can emerge,” says Heloisa Bordallo, an associate professor at the Niels Bohr Institute, and one of the two main authors of the research article just published in Scientific Reports.
Three dimensional insight
A major challenge of making an oral vaccine is to encapsulate it in a material that can endure the harsh conditions of our digestive system, to protect the vaccine from being destroyed before it reaches its intended destination in the body. The Danish research team’s collaborative partners in Brazil have long known that the silica-material SBA-15 is well-suited to encapsulate a hepatitis B vaccine. However, they did not know exactly how the material protected the vaccine. Nor were they certain about why their vaccine was not always completely effective.
This is where the team of Danish physicists came into the picture. Using a special technique that combines x-ray and neutron imaging, researchers at the Niels Bohr Institute were able to produce 3D images of the inside of the SBA-15 silica. It marked a crucial step in the use of this technique to develop pharmaceuticals. The imagery allows researchers to see how the vaccine behaves inside the silica, right down to the particle scale. Among other things, they were able to see that the vaccine had a tendency to clump within the silica, making it less effective.
“Now we know what makes the vaccine less effective, and how to optimize it. We know exactly how much vaccine should be put in the silica capsule for it to work best in the body and the clinical trials can be better interpreted,” explains Heloisa Bordallo.
No more swelling and inflammation
The vaccine is particularly promising for developing nations, explains the other main author, Martin K. Rasmussen, a former student at the Niels Bohr Institute and current doctoral student at DTU:
“Getting rid of needles being poked into the arms of little children is an advantage in and of itself. It also eliminates any need to sterilize needles and possible side effects such as swelling and infection. And, unlike the vaccine in use today, this type of vaccine needn’t be refrigerated. As such, costs will be reduced and the vaccine’s administration will be eased.”
The researchers hope that the 3D technology will also be used to develop oral vaccines against several other types of disease. The goal of the Danish researchers’ Brazilian collaborative partners is to produce a 6-in-1 oral vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B. The vaccine against diphtheria and tetanus is already being developed.
Learn more: Needleless vaccine will protect children from dangerous viruses
The Latest on: Oral vaccines
via Google News
The Latest on: Oral vaccines
- Nigeria: Health Ambassadors Boost Vaccine Coverage in Nigeria's Jigawa Stateon October 17, 2019 at 6:45 am
Community engagement strategy among other factors could have contributed to changing trajectory in routine immunization landscape in Jigawa State" For optimal protection against polio, children are ...
- HPV vaccine: Why your daughter must get the shot, your son tooon October 17, 2019 at 5:10 am
Apart from the anogenital cancers, HPV can also infect the mouth and throat and cause oropharyngeal cancer when one performs oral sex on an infected person. ALSO READ: Cervical cancer vaccine is not ...
- 274,000 Quezon City kids to receive polio vaccineon October 16, 2019 at 6:27 pm
MANILA, Philippines – The Quezon City government plans to provide oral polio vaccines to 274,785 children below five years old before the end of the year, Mayor Joy Belmonte said yesterday. Belmonte ...
- UAE ministry introduces new vaccine against polioon October 16, 2019 at 8:39 am
In a recent decree, the Ministry of Health and Prevention (Mohap) has suspended the use of oral polio vaccine, which is being administered to children at the age of four months. Instead, a vaccine ...
- Live Vaccines Market to Reach USD 24.95 Billion by 2026 | Reports And Dataon October 16, 2019 at 7:41 am
Reports and Data has segmented the live vaccines market on the basis of type, route of administration, application, patient use and region: Type Outlook (Revenue, USD Million; 2016-2026) * Viral * ...
- Polio Vaccine Market:Recent Changes and Regional Average Pricing Analysis, Trends and Forecast Report By 2027on October 16, 2019 at 6:26 am
The market is segmented by product type into inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV). Among these segments, oral poliovirus vaccine (OPV) segment is anticipated to hold ...
- Vaccines Market: Meticulous Research(R) Reveals Why This Market is Growing at a CAGR of 7.9% to Reach $57.5 Billion by 2025on October 16, 2019 at 2:26 am
MMR), route of administration (Intramuscular (IM), Subcutaneous (SC/SQ), Oral, and others), type (Subunit, recombinant, polysaccharide, and conjugate vaccines, inactivated vaccines, live-attenuated ...
- Philippine disease outbreaks linked to vaccine fearon October 14, 2019 at 7:23 am
“The problem is that our people have lost their vaccine confidence,” Bravo said. The decline in Philippine vaccination rates is seen in the latest report issued in July by WHO and UNICEF. The report ...
- Red Cross to join DOH polio vaccine campaignon October 13, 2019 at 11:34 am
PRC has a master list of the children who will receive the vaccination. Once vaccinated, a record will be made to make sure that no child will miss the two remaining doses of Oral Polio Vaccine (OPV).
- Biologists to distribute oral rabies vaccine baits for wildlife in southwest Virginiaon October 8, 2019 at 12:20 pm
ABINGDON, Va. (WDBJ7)-Wednesday, the United States Department of Agriculture (USDA) Wildlife Services will begin to distribute oral rabies vaccine (ORV) baits in areas of southwest Virginia. ORV baits ...
via Bing News